R Rosenquist
Overview
Explore the profile of R Rosenquist including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
1420
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smedby K, Wasterlid T, Tham E, Haider Z, Joelsson J, Thorvaldsdottir B, et al.
Acta Oncol
. 2023 Jul;
62(6):560-564.
PMID: 37415362
No abstract available.
2.
Technological readiness and implementation of genomic-driven precision medicine for complex diseases
Franks P, Melen E, Friedman M, Sundstrom J, Kockum I, Klareskog L, et al.
J Intern Med
. 2021 Jul;
290(3):602-620.
PMID: 34213793
The fields of human genetics and genomics have generated considerable knowledge about the mechanistic basis of many diseases. Genomic approaches to diagnosis, prognostication, prevention and treatment - genomic-driven precision medicine...
3.
Barbany G, Arthur C, Lieden A, Nordenskjold M, Rosenquist R, Tesi B, et al.
J Intern Med
. 2019 Mar;
286(2):118-136.
PMID: 30861222
In recent years, detection of cell-free tumour DNA (ctDNA) or liquid biopsy has emerged as an attractive noninvasive methodology to detect cancer-specific genetic aberrations in plasma, and numerous studies have...
4.
Malcikova J, Tausch E, Rossi D, Sutton L, Soussi T, Zenz T, et al.
Leukemia
. 2018 Feb;
32(5):1070-1080.
PMID: 29467486
In chronic lymphocytic leukemia (CLL), TP53 gene defects, due to deletion of the 17p13 locus and/or mutation(s) within the TP53 gene, are associated with resistance to chemoimmunotherapy and a particularly...
5.
Smedby K, Rosenquist R
J Intern Med
. 2017 Oct;
282(5):358-359.
PMID: 29052300
No abstract available.
6.
Rosenquist R, Bea S, Du M, Nadel B, Pan-Hammarstrom Q
J Intern Med
. 2017 Jun;
282(5):371-394.
PMID: 28631441
With the introduction of next-generation sequencing, the genetic landscape of the complex group of B-cell lymphoid malignancies has rapidly been unravelled in recent years. This has provided important information about...
7.
Rosenquist R, Ghia P, Hadzidimitriou A, Sutton L, Agathangelidis A, Baliakas P, et al.
Leukemia
. 2017 Apr;
31(7):1477-1481.
PMID: 28439111
No abstract available.
8.
Young E, Noerenberg D, Mansouri L, Ljungstrom V, Frick M, Sutton L, et al.
Leukemia
. 2016 Nov;
31(7):1547-1554.
PMID: 27890934
Recurrent mutations within EGR2 were recently reported in advanced-stage chronic lymphocytic leukemia (CLL) patients and associated with a worse outcome. To study their prognostic impact, 2403 CLL patients were examined...
9.
Stamatopoulos K, Agathangelidis A, Rosenquist R, Ghia P
Leukemia
. 2016 Nov;
31(2):282-291.
PMID: 27811850
The discovery of almost identical or 'stereotyped' B-cell receptor immunoglobulins (BcR IG) among unrelated patients with chronic lymphocytic leukemia (CLL) cemented the idea of antigen selection in disease ontogeny and...
10.
Parker H, Rose-Zerilli M, Larrayoz M, Clifford R, Edelmann J, Blakemore S, et al.
Leukemia
. 2016 Jun;
30(11):2179-2186.
PMID: 27282254
Histone methyltransferases (HMTs) are important epigenetic regulators of gene transcription and are disrupted at the genomic level in a spectrum of human tumours including haematological malignancies. Using high-resolution single nucleotide...